Similarly, the level of STC1 detected in peripheral blood (PB) of AML patients at diagnosis was significantly higher than in healthy controls (0.92 ng/mL ± 0.62 AML versus 0.23 ± 0.16 ng/mL control) (Figure 3E). Here, STC1 is linked to acute myeloid leukemia.